SCHEMBL18837951

SCHEMBL18837951

O=C[C@@H](O)[C@H](O)CCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21633313 1.00
SCHEMBL2338876 1.00
SCHEMBL15797071 1.00
SCHEMBL1746566 0.84 AKR1B1 (0.36)
SCHEMBL2338047 0.84 AKR1B1 (0.36)
SCHEMBL448041 0.84 AKR1B1 (0.36)
SCHEMBL7153437 0.84 AKR1B1 (0.36)
SCHEMBL17984934 0.84 MPI (0.39)
SCHEMBL14659599 0.82 AKR1B1 (0.35)
SCHEMBL16431695 0.82 AKR1B1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220259249-A1 INHIBITORS OF ANTIBIOTIC RESISTANCE MEDIATED BY ARNT UNIVERSITÀ DEGLI STUDI DI ROMA "LA SAPIENZA" (IT) 2022-08-18 US disclosed
EP-4003324-A1 INHIBITORS OF ANTIBIOTIC RESISTANCE MEDIATED BY ARN T Università degli Studi di Roma "La Sapienza" (IT) 2022-06-01 EP disclosed
EP-3374027-B1 RATIONAL DRUG DESIGN TARGETING RESISTANT GRAM-NEGATIVE BACTERIAL INFECTIONS TO POLYMYXIN-CLASS ANTIBIOTICS UNIV COLUMBIA (US) 2021-06-23 EP disclosed
US-10925857-B2 Rational drug design targeting resistant gram-negative bacterial infections to polymyxin-class antibiotics THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2021-02-23 US disclosed
WO-2021014422-A1 INHIBITORS OF ANTIBIOTIC RESISTANCE MEDIATED BY ARN T UNIVERSITÀ DEGLI STUDI DI ROMA "LA SAPIENZA" (IT) 2021-01-28 WO disclosed
US-20190231747-A1 RATIONAL DRUG DESIGN TARGETING RESISTANT GRAM-NEGATIVE BACTERIAL INFECTIONS TO POLYMYXIN-CLASS ANTIBIOTICS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2019-08-01 US disclosed
EP-3374027-A1 RATIONAL DRUG DESIGN TARGETING RESISTANT GRAM-NEGATIVE BACTERIAL INFECTIONS TO POLYMYXIN-CLASS ANTIBIOTICS The Trustees of Columbia University in the City of New York (US) 2018-09-19 EP disclosed
WO-2017083859-A1 RATIONAL DRUG DESIGN TARGETING RESISTANT GRAM-NEGATIVE BACTERIAL INFECTIONS TO POLYMYXIN-CLASS ANTIBIOTICS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2017-05-18 WO disclosed